Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Neutral

Price to Earnings Rating

Neutral

Analyst Rating

Buy

Simple Moving Average

Strong Buy

Exponential Moving Average

Strong Buy

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Buy

Insider Trading

Sell

Wall Street Data Solutions Rating

Buy

A

United Therapeutics Corp (UTHR)

Pharmaceutical Preparations

https://www.unither.com

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

1000 SPRING ST
SILVER SPRING, MD

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/17/1999

Market Cap

14,329,725,696

Shares Outstanding

46,990,000

Weighted SO

46,993,601

Total Employees

N/A

Upcoming Earnings

08/07/2024

Similar Tickers

INCY --.--%

ALNY --.--%

RARE --.--%

APLS --.--%

REPL --.--%

NUVL --.--%

VTYX --.--%

ASND --.--%

MNKD --.--%

Beta

0.5550

Last Div

0.0000

Range

208.62-343.98

Chg

-1.0000

Avg Vol

536975

Mkt Cap

14329725696

Exch

NASDAQ

Country

US

Phone

301 608 9292

DCF Diff

-109.3325

DCF

430.6224

Div Yield

0.0000

P/S

5.4763

EV Multiple

9.2472

P/FV

2.5101

Div Yield %

0.0000

P/E

13.3723

PEG

1.0468

Payout

0.0000

Current Ratio

4.3488

Quick Ratio

4.1848

Cash Ratio

1.6289

DSO

40.5494

DIO

170.7419

Op Cycle

211.2913

DPO

406.9037

CCC

-195.6124

Gross Margin

0.8885

Op Margin

0.4828

Pretax Margin

0.5354

Net Margin

0.4087

Eff Tax Rate

0.2367

ROA

0.1591

ROE

0.1882

ROCE

0.2144

NI/EBT

0.7633

EBT/EBIT

1.1091

EBIT/Rev

0.4828

Debt Ratio

0.0744

D/E

0.0878

LT Debt/Cap

0.0172

Total Debt/Cap

0.0807

Int Coverage

38.9907

CF/Debt

2.2112

Equity Multi

1.1801

Rec Turnover

9.0014

Pay Turnover

0.8970

Inv Turnover

2.1377

FA Turnover

2.3906

Asset Turnover

0.3892

OCF/Share

24.9009

FCF/Share

19.7725

Cash/Share

66.9257

OCF/Sales

0.4225

FCF/OCF

0.7940

CF Coverage

2.2112

ST Coverage

2.7640

CapEx Coverage

4.8555

Div&CapEx Cov

4.8555

P/BV

2.5101

P/B

2.5101

P/S

5.4763

P/E

13.3723

P/FCF

16.3227

P/OCF

12.9345

P/CF

12.9345

PEG

1.0468

P/S

5.4763

EV Multiple

9.2472

P/FV

2.5101

DPS

0.0000

Latest Headlines (EST)

MarketWatch Dec 30, 07:02 20 midcap stocks with 2024 upside ranging up to 62%, according to analysts MarketWatch Dec 26, 13:02 20 midcap stocks with 2024 upside ranging up to 62%, according to analysts MarketWatch Dec 26, 13:02 20 midcap stocks with 2024 upside ranging up to 62%, according to analysts

Revenue Product Segmentation